Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Niethammer, AG; Xiang, R; Becker, JC; Wodrich, H; Pertl, U; Karsten, G; Eliceiri, BP; Reisfeld, RA.
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth.
Nat Med. 2002; 8(12):1369-1375 Doi: 10.1038/nm794
Web of Science PubMed FullText FullText_MUG Google Scholar

Co-authors Med Uni Graz: Becker Jürgen Christian
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Tumor cells are elusive targets for immunotherapy due to their heterogeneity and genetic instability. Here we describe a novel, oral DNA vaccine that targets stable, proliferating endothelial cells in the tumor vasculature rather than tumor cells. Targeting occurs through upregulated vascular-endothelial growth factor receptor 2 (FLK-1) of proliferating endothelial cells in the tumor vasculature. This vaccine effectively protected mice from lethal challenges with melanoma, colon carcinoma and lung carcinoma cells and reduced growth of established metastases in a therapeutic setting. CTL-mediated killing of endothelial cells indicated breaking of peripheral immune tolerance against this self antigen, resulting in markedly reduced dissemination of spontaneous and experimental pulmonary metastases. Angiogenesis in the tumor vasculature was suppressed without impairment of fertility, neuromuscular performance or hematopoiesis, albeit with a slight delay in wound healing. Our strategy circumvents problems in targeting of genetically unstable tumor cells. This approach may provide a new strategy for the rational design of cancer therapies.
Find related publications in this database (using NLM MeSH Indexing): Animals -; CD8-Positive T-Lymphocytes - immunology; Cell Line -; Cytotoxicity, Immunologic -; Lung Neoplasms - secondary; Mice -; Mice, Inbred C57BL -; Neoplasms, Experimental - blood supply; Neovascularization, Pathologic - prevention and control; Vaccination -; Vaccines, DNA - immunology; Vascular Endothelial Growth Factor Receptor-2 - immunology; Wound Healing -